利用人工智慧對抗抗生素抗藥性細菌
Using AI to Fight Antibiotic-Resistant Bacteria
Updated at: June 26, 2026 at 10:30 AM
抗生素耐藥性是一項日益嚴重的全球性威脅，常被稱為「隱形大流行」。
Antibiotic resistance is a growing global threat often called the silent pandemic.
傳統的藥物研發既緩慢又不可預測，但人工智慧(AI)正在改變這一局面。
Traditional drug development is slow and unpredictable, but artificial intelligence is changing the game.
透過使用機器學習，研究人員可以在幾天內篩選數百萬種化合物，而這一過程過去需要耗費數年。
By using machine learning, researchers can scan millions of chemical compounds in days, a process that used to take years.
AI不僅僅是在篩選現有的藥物；生成式模型現在還能設計出進化從未產生過的全新分子，有助於繞過細菌的抗藥性。
AI is not just screening existing drugs; generative models can now design entirely new molecules that evolution has never created, helping to bypass bacterial resistance.
除了藥物研發之外，AI還能透過在數小時內識別抗生素的敏感性來改善診斷。
Beyond drug discovery, AI improves diagnostics by identifying antibiotic susceptibility in hours instead of days.
這種轉變使醫生能更快地開出針對性的治療方案。
This shift allows doctors to prescribe targeted treatments much faster.
此外，科學家們正致力於「可解釋的AI」，以了解這些模型如何預測藥物的有效性。
Furthermore, scientists are working on 'explainable AI' to understand how these models predict drug effectiveness.
歸根結底，將AI整合到醫學中，可以實現一種更具主動性、更精確的方法來對抗傳染病，讓我們在與不斷演化的細菌博弈中領先一步。
Ultimately, integrating AI into medicine allows for a more proactive, precise approach to fighting infectious diseases, keeping us one step ahead of evolving bacteria.
